Bookmark Website  | Free Registration  | The Team
The Lounge  | Champions  | The Wire |  Schedule |  Audio  |  Arcade  |  The Top Ten  |  Historical  |  Email  |  Video

Congestive Heart Failure And CoQ10


Since the 1960â??s there have been numerous controlled clinical trials concerning the relationship between congestive heart failure and Coenzyme Q10 (CoQ10). As its name implies CoQ10 is a coenzyme that is necessary for the proper functioning of other substances, one of the most important of which is ATP (adenosine triphosphate). ATP is necessary for the production of cellular energy. By proxy CoQ10 is likewise essential for this process.

Clinical trials have attempted to study the relationship between CoQ10 and many chronic diseases including, but not limited to, heart disease, cancer and AIDS. But heart disease has gained the most attention; congestive heart failure being one of the primary subjects. Because heart muscle cells require so much energy to function and CoQ10 is at the core of the cellular energy process it makes sense to suspect that congestive heart failure might be linked to CoQ10 deficiency. With that theory in mind many studies like the ones that follow have been conducted. These trials have been presented in this essay in thumbnail format.

One early Japanese trial (1972) involved 197 patients with varying levels of severity of cardiac failure. The study reported significant improvement of cardiac function supplementing with 30 mg per day of CoQ10. Another Japanese study demonstrated similar results with 38 patients also supplementing with 30 mg. In 1985 a U.S. clinical study prescribed daily supplementation with 100 mg of the coenzyme for treatment periods of three months for patients with low ejection fraction measurements. The ejection fraction is the measure of the heartâ??s ability to pump blood. A low ejection fraction is a classic symptom of congestive heart failure. Again, significant improvements in heart function were reported. Other clinical trials followed prescribing the same level of supplementation with similar results.

Studies in the early 1990s showed improvement for patients suffering from ischemic cardiomyopathy (a low oxygen state usually due to obstruction) with supplemental levels of 200 mg per day. Supplementing with 100 mg per day demonstrated improvement for patients suffering from idiopathic dilated cardiomyopathy, an enlarged heart syndrome of unknown cause.

One of the largest trials of the 1990s involves 641 patients randomly divided into two groups. The first group received a placebo. The other group received CoQ10 supplements. During the one-year follow-up period 118 patients in the placebo group were hospitalized for heart failure compared to 73 in the group that received the supplements.

All of the preceding trials were relatively short-term studies. The level of improvement among patients varied depending on how long they had been suffering from some aspect of congestive heart failure. Through the years it has become increasing clear that the greatest improvements were shown in patients that had suffered from their condition the least amount of time.

In other words, the longer a person had been suffering from the disease before he or she received CoQ10 treatments the less improvement was demonstrated. People who had received treatments early in the development of the disease showed the most dramatic improvement often returning to normal heart function. Long-term sufferers received less relief and were less likely to return to full heart function. Whatever the reasons for this disparity in health improvement, it demonstrates the importance of receiving treatment as early as possible.

But what about long-term studies? Do they show the same marked improvement with similar treatment? In the short-term trials it was apparent that even high level supplementing with CoQ10 seemed to produce no ill effects. In order to determine if this is only true for short durations a number of long-term studies were conducted.

In 1990 observations were published concerning 126 patients with dilated cardiomyopathy. Unlike previously noted studies this one followed the patientsâ?? progress for six years. Long-term benefits from CoQ10 supplementing were noticed with no harmful side effects. Similar observations were made in a trial involving 2,664 patients treated with CoQ10 at levels up to 150 mg per day.

A 1994 study involving 424 patients with a variety of myocardial (refers to the heart's muscle mass) diseases. Among these conditions were the following: Valvular heart disease (pertaining to dysfunction of heart valves), hypertension, diastolic dysfunction (failure of the heart to properly refill itself with blood), dilated cardiomyopathy (group of disorders where the heart muscle is weakened and enlarged and cannot pump effectively) and ischemic cardiomyopathy (low oxygen state usually due to obstruction of the arterial blood supply).

Patients were treated with an average of 240 mg of CoQ10 daily during their treatment period. They were then followed-up for up to eight years with an average follow-up period of 18 months. Overall results demonstrated measurable cardiac improvements in one month with maximum improvements at about six months. With continued CoQ10 treatment the improvement in most patients was sustained. However, discontinuing the treatment usually resulted in a decline of cardiac function with eventual return to pre-treatment conditions.

As always in the medical community many more studies will need to be conducted to determine the future of CoQ10 treatment. However, the research to date seems to support CoQ10 as a viable treatment for many diseases that are caused or exacerbated by inadequate production of cellular energy.

Greg holds degrees in science, divinity and philosophy and is currently an I.T. developer.

http://www.optimal-heart-health.com/coq10.html


MORE RESOURCES:

Empowered Products Wins XBIZ Award for Sexual Supplement Company of the Year
Sacramento Bee
OB – News) an emerging leader in the high-growth sexual wellness sector through its trademark PINK® and GunOil® brands, announces that it has received the 2012 XBIZ Sexual Supplement Company of the Year award. The 10th anniversary show of the XBIZ ...

and more »


Altrient, Maker of High-Performance Nutritional Supplements, Joins "Balance ...
MarketWatch (press release)
9, 2012 /PRNewswire via COMTEX/ -- Altrient(TM), Inc., a maker of high-performance nutritional supplements, joins the "Balance Your Life Road Tour" 2012 when it kicks off Feb. 17-19 in Savannah, GA at the Savannah International Trade & Convention ...

and more »


MMA Elite Supplements Powered by MusclePharm Now Available at Wal-Mart
SYS-CON Media (press release)
9, 2012 /PRNewswire/ -- MusclePharm Corporation, a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: MSLP), an expanding US nutritional supplement company, is pleased to announce that MMA Elite Supplements powered by MusclePharm are now ...



PR Web (press release)

The A-C of vitamins
FemaleFirst.co.uk
Nobody should take more than 1.5mg a day of vitamin A, and there is no group of adults who need supplements if they have a reasonable diet including eggs, dairy products or oily fish. In fact, taking too much is a more common risk than too little, ...
All Natural Whole Food Vitamin Supplement Now Available From Nutrition Company ...PR Web (press release)
Have a Question About Vitamins? Ask Your PharmacistMarketWatch (press release)
Boom in Demand for Liquid Supplements is Set to Transform the $7 Billion ...DigitalJournal.com (press release)
BoldSky
all 9 news articles »


Dietary Supplement Maker Doctor's Best, Inc., Appoints Dr. Parris M. Kidd as ...
MarketWatch (press release)
SAN CLEMENTE, Calif., Feb 08, 2012 (BUSINESS WIRE) -- Doctor's Best, Inc., a leading manufacturer and distributor of clinically-formulated dietary supplements, announced that dietary supplement industry researcher, product developer and educator Parris ...

and more »


Choose your supplements with care
Vancouver Sun
Supplements are an excellent way to bolster our diets and provide hard-to-find nutrients that our bodies need. But as Peter Jones, director of the Richardson Centre for Functional Foods and Nutraceuticals at the University of Manitoba, explains, ...

and more »


Rough Draft: Dietary Supplement Industry Arguments Against FDA's NDI Draft ...
Nutritional Outlook
By Jennifer Grebow February 8, 2012 0 Comments Saying that the dietary supplements industry is unsatisfied with FDA's new dietary ingredient (NDI) draft guidance is an understatement. "Atrium Innovations firmly believes in the intended principle ...

and more »


TopNews Arab Emirates

Diet supplements recalled on unlabeled drug worries
Fox News
iStock Print Email Share Comments Recommend Tweet Healthy People Co is recalling 15 lots of seven different dietary supplements because they contain appetite suppressants or a drug for male erectile dysfunction, the Long Beach, California, company said ...
Dietary Supplements Extensively Regulated, Say Authors of New ArticleMarketWatch (press release)
ABC Article Outlines Supplement Regulation MythsNatural Products INSIDER
FDA taking away your vitamins?WND.com
News-Medical.net
all 33 news articles »


Baltimore Sun

Soy Isoflavone Supplementation Not Effective In Breast Cancer Protection
Medical News Today
A study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, reveals that breast cancer cell proliferation was not lowered with soy isoflavone supplements in a randomized human trial.
Soy pills not helpful for breast cancer prevention, study saysLos Angeles Times
Soy supplements may not protect against breast cancerHealthJockey.com
Soy Isoflavones Don't Reduce Breast Epithelial ProliferationDoctors Lounge

all 9 news articles »


Life Extension Rated Number One by Dietary Supplement Consumers in Four ...
Sacramento Bee
8, 2012 -- /PRNewswire/ -- Life Extension, offering superior-quality dietary supplements to consumers and a pioneer in funding and reporting the latest anti-aging research and integrative health therapies, has been rated number one in four categories ...

and more »

Google News


Advertisement



Section Site Map - Submit News - Feedback - Comments - Advertise with Us

Copyright © 2006 Luminati Inc. All rights reserved.